Article Details

FDA Approves TEZSPIRE™ (tezepelumab-ekko), AstraZeneca and Amgen's First-in-Class ...

Retrieved on: 2021-12-22 15:08:51

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves TEZSPIRE™ (tezepelumab-ekko), AstraZeneca and Amgen's First-in-Class .... View article details on HISWAI: https://www.prnewswire.com/news-releases/fda-approves-tezspire-tezepelumab-ekko-astrazeneca-and-amgens-first-in-class-treatment-for-severe-asthma-301449804.html

Excerpt

PRNewswire/ -- Brand Institute is proud to announce its successful partnership with AstraZeneca and Amgen in naming TEZSPIRE™, the first and only ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up